REBEL Cast Ep 118: The PROCOAG Trial – 4F-PCC for Trauma Patients?
REBEL EM
JUNE 26, 2023
This could potentially help improve thrombin generation, reduce blood product consumption, but also could increase the risk of thromboembolic events. Click here for Direct Download of the Podcast Paper: Bouzat P et al. High-quality studies are needed to determine the utility of this intervention. to 3.33; P = 0.72 to 2.10; P = 0.03
Let's personalize your content